GB0318546D0 - Quinoxalinones and their use - Google Patents
Quinoxalinones and their useInfo
- Publication number
- GB0318546D0 GB0318546D0 GBGB0318546.9A GB0318546A GB0318546D0 GB 0318546 D0 GB0318546 D0 GB 0318546D0 GB 0318546 A GB0318546 A GB 0318546A GB 0318546 D0 GB0318546 D0 GB 0318546D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- quinoxalinones
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0318546A GB2404658A (en) | 2003-08-07 | 2003-08-07 | Quinoxalinone derivatives and their use in the treatment of diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0318546A GB2404658A (en) | 2003-08-07 | 2003-08-07 | Quinoxalinone derivatives and their use in the treatment of diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB0318546D0 true GB0318546D0 (en) | 2003-09-10 |
| GB2404658A GB2404658A (en) | 2005-02-09 |
Family
ID=27839817
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0318546A Withdrawn GB2404658A (en) | 2003-08-07 | 2003-08-07 | Quinoxalinone derivatives and their use in the treatment of diseases |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2404658A (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX361539B (en) | 2012-04-25 | 2018-12-10 | Takeda Pharmaceuticals Co | Nitrogenated heterocyclic compound. |
| US9527841B2 (en) | 2012-07-13 | 2016-12-27 | Takeda Pharmaceutical Company Limited | Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitors |
| EP2975031A4 (en) | 2013-03-14 | 2017-04-19 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| WO2015002230A1 (en) | 2013-07-03 | 2015-01-08 | 武田薬品工業株式会社 | Amide compound |
| EP3018126A4 (en) | 2013-07-03 | 2016-12-07 | Takeda Pharmaceuticals Co | Heterocyclic compound |
| EP2949648A1 (en) | 2014-05-30 | 2015-12-02 | IEO - Istituto Europeo di Oncologia Srl | Cyclopropylamine derivatives as histone demethylase inhibitors |
| WO2015181380A1 (en) | 2014-05-30 | 2015-12-03 | Ieo - Istituto Europeo Di Oncologia S.R.L. | Cyclopropylamine compounds as histone demethylase inhibitors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10205219A1 (en) * | 2002-02-08 | 2003-08-21 | Bayer Ag | Quinoxalinones and their use |
-
2003
- 2003-08-07 GB GB0318546A patent/GB2404658A/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| GB2404658A (en) | 2005-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1088837A1 (en) | Clk-peptide and slk-peptide | |
| GB0318546D0 (en) | Quinoxalinones and their use | |
| GB0300804D0 (en) | Compounds and their use | |
| GB0300805D0 (en) | Compounds and their use | |
| GB0301143D0 (en) | Compounds and their use | |
| GB0317133D0 (en) | Compounds and their use | |
| GB0314295D0 (en) | Compounds and their use | |
| GB0316114D0 (en) | Compounds and their use | |
| GB0317283D0 (en) | Compounds and their use | |
| GB0301146D0 (en) | Compounds and their use | |
| GB0322658D0 (en) | Compounds and their use | |
| GB0323000D0 (en) | Compounds and their use | |
| GB0323470D0 (en) | Compounds and their use | |
| GB0317281D0 (en) | Compounds and their use | |
| GB0324209D0 (en) | Compounds and their use | |
| GB0324579D0 (en) | Compounds and their use | |
| GB0324581D0 (en) | Compounds and their use | |
| GB0324877D0 (en) | Compounds and their use | |
| GB0325620D0 (en) | Compounds and their use | |
| GB0316113D0 (en) | Compounds and their use | |
| GB0317279D0 (en) | Compounds and their use | |
| GB0301147D0 (en) | Compounds and their use | |
| GB0316108D0 (en) | Compounds and their use | |
| GB0320064D0 (en) | Compounds and their use | |
| GB0314293D0 (en) | Compounds and their use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |